Lobbying Activity Report

5271-32062

Designated Filer name: Michael McLean
Client: CSL Behring Canada Inc.
Associated registration: 9735-5271-1
Lobbying Activity date: 2024-01-22
Arranged a meeting: No
Posted date: 2024-02-15

Senior Public Office Holders who were lobbied in this activity: Tijana Fazlagic, Executive Director
Therapeutic Assessment &Access Branch, Health

Mitch Moneo, Assistant Deputy Minister
Pharmaceutical, Laboratory & Blood Services Division, Health
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
The goal will be to increase awareness about CSL Behring Canada as an innovative biotherapeutics company. Additionally there will be discussions about British Columbia's anticipated policies and procedures to provide patient access for new novel therapies including gene therapy for the treatment of Hemophilia-B.
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 Health
Date Modified: